Remdesivir emergency supplies to hospitals: Gilead coronavirus drug - Business Insider

Canada News News

Remdesivir emergency supplies to hospitals: Gilead coronavirus drug - Business Insider
Canada Latest News,Canada Headlines
  • 📰 BusinessInsider
  • ⏱ Reading Time:
  • 37 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 18%
  • Publisher: 51%

Hospitals are stuck waiting for supplies of a promising coronavirus treatment to arrive, days after health authorities OK'd its emergency use

Dr. Tony Reed, the chief medical officer at Temple University Hospital in Philadelphia, has seen remdesivir in action. The hospital system gave the drug to patients in trials to help figure out how well the coronavirus treatment works.on Friday, saying the treatment could help some severely ill patients recover more quickly, Reed and the team at Temple expected that they'd get more access to the medication.

As the government figures out which hospitals will get the drug, severely ill patients who should qualify for treatment aren't getting it, doctors across the country told Business Insider.In some cases, hospitals don't have the drug on hand yet, or aren't able to give it to patients outside the narrow confines of clinical trials. Clinicians said they aren't sure when it will come or how much supply they'll get.

Any delay may be harmful to patients. Antivirals like remdesivir generally work better when given earlier on in the course of an infection. Gilead Sciences, the biotech company that makes remdesivir, has put out some preliminary data suggesting that may be the case with this drug as well.

We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:

BusinessInsider /  🏆 729. in US

Canada Latest News, Canada Headlines

Similar News:You can also read news stories similar to this one that we have collected from other news sources.

Will Gilead price its coronavirus drug for public good or company profit?Will Gilead price its coronavirus drug for public good or company profit?Gilead Sciences Inc faces a new dilemma in deciding how much it should profit from the only treatment so far proven to help patients infected with the novel coronavirus.
Read more »

Who can make Gilead's coronavirus drug, licence free?Who can make Gilead's coronavirus drug, licence free?Gilead Sciences Inc is in talks with chemical and drug makers to produce its experimental drug remdesivir, a potential coronavirus treatment, for Europe, Asia and the developing world, the firm has said.
Read more »

Supply chain expert: Coronavirus a 'learning experience' for companies - Business InsiderSupply chain expert: Coronavirus a 'learning experience' for companies - Business InsiderThe disrupted supply chains that left store shelves devoid of toilet paper and cleaning supplies could end up being a good lesson for American companies
Read more »

'Call of Duty' publisher Activision funding coronavirus drug research - Business Insider'Call of Duty' publisher Activision funding coronavirus drug research - Business InsiderThe latest 'Call of Duty' has been a sales smash as many people are stuck indoors. Now, its publisher is funding coronavirus-fighting drugs.
Read more »

Plant-Based Meat Business Booming Amid Beef and Poultry ShortagePlant-Based Meat Business Booming Amid Beef and Poultry ShortagePlant-based meat business is booming as a meat and poultry shortage looms amid coronavirus pandemic.
Read more »

Influencers won't be destroyed by the coronavirus advertising meltdown - Business InsiderInfluencers won't be destroyed by the coronavirus advertising meltdown - Business InsiderCreators and marketers are adjusting their businesses amid the coronavirus proving the influencer industry isn't destroyed.
Read more »



Render Time: 2025-03-17 08:19:05